ГИПЕРБАРИЧЕСКАЯ ОКСИГЕНАЦИЯ В КЛИНИЧЕСКОЙ И СПОРТИВНОЙ ПРАКТИКЕ
Обзорная статья
Дата публикации: апреля 26, 2022
Ключевые слова
гипербарическая оксигенация
инсульт
онкология
инсульт
онкология
Как цитировать
[1]
В. И. Пустовойт и Р. В. Никонов, ГИПЕРБАРИЧЕСКАЯ ОКСИГЕНАЦИЯ В КЛИНИЧЕСКОЙ И СПОРТИВНОЙ ПРАКТИКЕ, КМКВ, вып. 1, сс. 78-86, апр. 2022.
Аннотация
Гипербарическая оксигенация (ГБО), или оксигенобаротерапия, – это дыхание 100%-ным кислородом под давлением, превышающим 1 Ата, по медицинским показаниям. Данный метод появился как направление водолазной медицины и в настоящее время широко используется в терапевтических целях для лечения большого количества патологических состояний. Несмотря на то что первые шаги по изучению воздействия кислорода на организм человека и животных были предприняты Д. Пристли в конце XVIII столетия, внедрение в практическую медицину началось только в середине XX века. На сегодняшний день немногие клиницисты осведомлены в достаточной степени об эффективности этой процедуры. Данный обзор литературы посвящен научно-практическим аспектам применения ГБО и перспективам его развития в клинической и спортивной медицине.Литература
1. Lee C.H. et al. Top-cited articles on hyperbaric oxygen therapy published from 2000 to 2010 // Undersea Hyperb Med. – 2012. – V. 39. – № 6. – P. 1089–1098.
2. Mathieu D., Marroni A., Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment // Diving Hyperb Med. – 2017 – V. 47. – № 1. – P. 24–32.
3. Zeng Y. et al. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma // Brain Res. – 2012. – V. 3. – № 1452. – P. 140–50.
4. Hentia C. et al. An overview of protective strategies against ischemia/reperfusion injury: the role of hyperbaric oxygen preconditioning // Brain Behav. – 2018. – V. 30. – № 8. – P. 5.
5. Cozene B. et al. An extra breath of fresh air: hyperbaric oxygenation as a stroke therapeutic // Biomolecules. – 2020. – V. 10. – № 9. – P. 1279.
6. Hadanny A. et al. Hyperbaric oxygen therapy – basics and new applications // Harefuah. – 2018. – V. 157. – № 5. – P. 322–326.
7. Hadanny A. et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis // Restor Neurol Neurosci. – 2020. – V. 38. – № 1. – P. 93–107.
8. Liang X.X. et al. Hyperbaric oxygen therapy for post-stroke depression: a systematic review and meta-analysis // Clin Neurol Neurosurg. – 2020. – V. 195. – P. 105910.
9. Schiavo S. et al. Hyperbaric oxygen and focused rehabilitation program: a feasibility study in improving upper limb motor function after stroke // Appl Physiol Nutr Metab. – 2020. – V. 45. – № 12. – P. 1345–1352.
10. Sankaran R., Radhakrishnan K., Sundaram K.R. Hyperbaric oxygen therapy in patients with hypoxic ischemic encephalopathy // Neurol India. – 2019. – V. 67. – № 3. – P. 728–731.
11. Golan H. et al. Imaging-based predictors for hyperbaric oxygen therapy outcome in post-stroke patients. Report 1 // Med Hypotheses. – 2020. – V. 136. – P. 109510.
12. Deng Z. et al. The neuroprotection effect of oxygen therapy: a systematic review and meta-analysis // Niger J Clin Pract. – 2018. – V. 21. – № 4. – P. 401–416.
13. Daly S. et al. Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review // J Neurotrauma. – 2018. – V. 35. – № 4. – P. 623–629.
14. Zhong X. et al. Hyperbaric oxygen for severe traumatic brain injury: a randomized trial // J Int Med Res. – 2020. – V. 48. – № 10. – P. 300060520939824.
15. Boussi-Gross R. et al. Hyperbaric oxygen therapy can improve post-concussion syndrome years after mild traumatic brain injury – а randomized prospective trial // PLoS One. – 2013. – V. 8. – № 11. – P. e79995.
16. Sutherland A.M. Hyperbaric oxygen therapy: a new treatment for chronic pain? // Pain Pract. – 2016. – V. 16. – № 5. – P. 620–628.
17. Zelinski L.M. et al. A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice // J Pain. – 2009. – V. 10. – № 2. – P. 167–172.
18. Chung E.et al. Hyperbaric oxygen treatment induces a 2-phase antinociceptive response of unusually long duration in mice // J Pain. – 2010. – V. 11. – № 9. – P. 847–853.
19. Hui J. et al. Repetitive hyperbaric oxygen treatment attenuates complete Freund's adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord // J Pain. – 2013. – V. 14. – № 7. – P. 747–758.
20. Bennett M.H. et al. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache // Cochrane Database Syst Rev. – 2015. – V. 28. – № 12. – P. CD005219.
21. Atzeni F. et al. Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system // Clin Exp Rheumatol. – 2020. – V. 38. – Suppl. 123. – № 1. – P. 94–98.
22. Kusuda Y. et al. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantianigra of mice with MPTP-induced Parkinson's disease // Neurosci Res. – 2018. – V. 132. – P. 58–62.
23. Uezato A. et al. Shorter sleep onset latency in patients undergoing hyperbaric oxygen treatment // Psychiatry Clin Neurosci. – 2017. – V. 71. – № 1. – P. 73–74.
24. Hyldegaard O., Hedetoft M. Hyperbaric oxygen therapy // Ugeskr Laeger. – 2020. – V. 182. – № 44. – P. V06200463.
25. Wu Z.S. et al. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model // Int J Mol Sci. – 2018. – V. 19. – № 8. – P. 2195.
26. Memar M.Y. et al. Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections // Biomed Pharmacother. – 2019. – V. 109. – P. 440–447.
27. Lam G. et al. Hyperbaric oxygen therapy: exploring the clinical evidence // Adv Skin Wound Care. – 2017. – V. 30. – № 4. – P. 181–190.
28. Gunes A.E., Cimsit M. Can amputation be prevented in diabetic foot? Interdisciplinary approach to diabetic foot: a case report // Undersea Hyperb Med. – 2017. – V. 44. – № 2. – P. 157–160.
29. Chen C.Y. et al. Adjunctive hyperbaric oxygen therapy for healing of chronic diabetic foot ulcers: a randomized controlled trial // J Wound Ostomy Continence Nurs. – 2017. – V. 44. – № 6. – P. 536–545.
30. Bolton L. Does hyperbaric oxygen improve lower extremity ulcer outcomes? // Wounds. – 2020. – V. 32. – № 10. – P. 291–293.
31. Henshaw F.R., Brennan L., MacMillan F. Perceptions of hyperbaric oxygen therapy among podiatrists practicing in high-risk foot clinics // Int Wound J. – 2018. – V. 15. – № 3. – P. 375–382.
32. Kahraman C., Yaman H. Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats // Turk J Med Sci. – 2021. – V. 51. – № 3. – P. 1572–1578.
33. Charaghvandi D.A., Teguh D.N., van Hulst R.A. Hyperbaric oxygen therapy in patients suffering from wounds in calciphylaxis: a narrative review // Undersea Hyperb Med. – 2020. – V. 47. – № 1. – P. 111–123.
34. Koh S.L. et al. The effect of hyperbaric oxygen on apoptosis and proliferation in severe acute pancreatitis // HPB (Oxford). – 2009. – V. 11. – № 8. – P. 629–637.
35. Bai X., Song Z., Zhou Y. et al. The apoptosis of peripheral blood lymphocytes promoted by hyperbaric oxygen treatment contributes to attenuate the severity of early stage acute pancreatitis in rats // Apoptosis. – 2014. – V. 19. – № 1. – P. 58–75.
36. Christophi C. et al. Hyperbaric oxygen therapy for severe acute pancreatitis // J Gastroenterol Hepatol. – 2007. – V. 22. – № 11. – P. 2042–2046.
37. Weitgasser L. et al. Update on hyperbaric oxygen therapy in burn treatment // Wien Klin Wochenschr. – 2021. – V. 133. – № 3–4. – P. 137–143.
38. Edwards M. et al. Hyperbaric treatment of thermal burns // StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
39. Halbach J.L. et al. Early hyperbaric oxygen therapy improves survival in a model of severe sepsis // Am J Physiol Regul Integr Comp Physiol. – 2019. – V. 317. – № 1. – P. 160–168.
40. Harl M.J. Defining the role of hyperbaric oxygen therapy as an adjunct to reconstructive surgery // Surg Clin North Am. – 2020. – V. 100. – № 4. – P. 777–785.
41. Bush N., Snodgrass W. Hyperbaric oxygen therapy improves oral graft take in hypospadias staged tubularized autograft reoperations // J Urol. – 2019. – V. 202. – № 3. – P. 617–622.
42. Fan Z.X. et al. The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia // J Cosmet Dermatol. – 2021. – V. 20. – № 3. – P. 917–921.
43. Willy C., Rieger H., Vogt D. Hyperbare oxygenation bei nekrotisieren den Weichteilinfektionen: Kontra // Chirurg. – 2012. – V. 83. – № 11. – P. 960–972.
44. Levett D., Bennett M.H., Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis // Cochrane Database Syst Rev. – 2015. – V. 1. – № 1. P. CD007937.
45. Schmale M. et al. Hyperbare oxygenation bei nekrotisieren den Weichteilinfektionen: Pro // Chirurg. – 2012. – V. 83. – № 11. – P. 973–979.
46. Shaw J.J. et al. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections // Surg Infect (Larchmt). – 2014. – V. 15. – № 3. – P. 328–335.
47. Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer – a review // Target Oncol. – 2012. – V. 7. – № 4. – P. 233–242.
48. Stępień K., Ostrowski R.P., Matyja E. Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours // Med Oncol. – 2016. – V. 33. – № 9. – P. 101.
49. Zembrzuska K., Ostrowski R.P., Matyja E. Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro // Oncol Rep. – 2019. – V. 41. – № 5. – P. 2703–2716.
50. Chen S.Y. et al. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer // Sci Rep. – 2021. – V. 11. – № 1. – P. 12033.
51. Oscarsson N. et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2–3 trial // Lancet Oncol. – 2019. – V. 20. – № 11. – P. 1602–1614.
52. Feldmeier J.J. Hyperbaric oxygen for radiation cystitis // Lancet Oncol. – 2019. – V. 20. – № 11. – P. 1481–1482.
53. Clarke R. Radiation-induced cystitis and hyperbaric oxygen therapy // Lancet Oncol. – 2019. – V. 20. – № 12. – P. e660.
54. Buckey J.C. Use of gases to treat cochlear conditions // Front Cell Neurosci. – 2019. – V. 24. – № 13. – P. 155.
55. Bayoumy A.B. et al. Effect of hyperbaric oxygen therapy and corticosteroid therapy in military personnel with acute acoustic trauma // BMJ Mil Health. – 2020. – V. 166. – № 4. – P. 243–248.
56. Holy R. et al. The use of hyperbaric oxygen therapy and corticosteroid therapy in acute acoustic trauma: 15 years' experience at the Czech military health service // Int J Environ Res Public Health. – 2021. – V. 18. – № 9. – P. 4460.
57. Cobanoglu H.B. et al. Is hyperbaric oxygen therapy effective in cisplatin-induced ototoxicity in rats? // Clin Exp Otorhinolaryngol. – 2019. – V. 12. – № 1. – P. 66–71.
58. Ajduk J. et al. Hyperbaric oxygen therapy as salvage therapy for sudden sensorineural hearing loss // J Int Adv Otol. – 2017. – V. 13. – № 1. – P. 61–64.
59. Cho I. et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial // Audiol Neurootol. – 2018. – V. 23. – № 4. – P. 199–207.
60. Stachler R.J. et al. Clinical practice guideline: sudden hearing loss // Otolaryngol Head Neck Surg. – 2012. – V. 146. – № 3. – P. 1–35.
61. Bagli B.S. Clinical efficacy of hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss // Undersea Hyperb Med. – 2020. – V. 47. – № 1. – P. 51–56.
62. Murphy-Lavoie H. et al. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss // Undersea Hyperb Med. – 2012. – V. 39. – № 3. – P. 777–792.
63. van der Wal A.W., van Ooij P.J.A.M., de Ru J.A. Hyperbaric oxygen therapy for sudden sensorineural hearing loss in divers // J Laryngol Otol. – 2016. – V. 130. – № 11. – P. 1039–1047.
64. Hu Y. et al. The efficacy of hyperbaric oxygen in the treatment of sudden sensorineural hearing loss // Lin Chung Er Bi Yan HouTou Jing Wai Ke Za Zhi. – 2020. – V. 34. – № 6. – P. 521–523; 527.
65. Olex-Zarychta D. Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss // Int J Mol Sci. – 2020. – V. 21. – № 22. – P. 8588.
66. Yang C.C. et al. The occurrence of delayed neuropsychologic sequelae in acute carbon monoxide poisoning patients after treatment with hyperbaric or normobaric oxygen therapy // Medicine (Baltimore). – 2021. – V. 100. – № 2. – P. e24183.
67. Zhang L. et al. Hyperbaric oxygen therapy mobilized circulating stem cells and improved delayed encephalopathy after acute carbon monoxide poisoning with up-regulation of brain-derived neurotrophic factor // Am J Emerg Med. – 2021. – V. 42. – P. 95–100.
68. Açiksari K. et al. Protective effect of hyperbaric oxygen treatment on rat intestinal mucosa after mesenteric ischaemia and reperfusion // Diving Hyperb Med. – 2019. – V. 49. – № 4. – P. 253–258.
69. Leitman M. et al. The effect of hyperbaric oxygenation therapy on myocardial function // Int J Cardiovasc Imaging. – 2020. – V. 36. – № 5. – P. 833–840.
70. Bennett M.H., Lehm J.P., Jepson N. Hyperbaric oxygen therapy for acute coronary syndrome // Cochrane Database Syst Rev. – 2015. – V. 2015. – № 7. – P. CD004818.
71. Gardin C. et al. Hyperbaric oxygen therapy improves the osteogenic and vasculogenic properties of mesenchymal stem cells in the presence of inflammation in vitro // Int J Mol Sci. – 2020. – V. 21. – № 4. – P. 1452.
72. Fosen K.M., Thom S.R. Hyperbaric oxygen, vasculogenic stem cells, and wound healing // Antioxid Redox Signal. – 2014. – V. 21. – № 11. – P. 1634–1647.
73. Kirby J.P. The diagnosis of decompression sickness in sport divers // Mo Med. – 2019. – V. 116. – № 3. – P. 195–197.
74. Butler G.J. et al. Altitude mountain sickness among tourist populations: a review and pathophysiology supporting management with hyperbaric oxygen // J Med Eng Technol. – 2011. – V. 35. – № 3–4. – P. 197–207.
75. Hartman-Ksycińska A., Kluz-Zawadzka J., Lewandowski B. High altitude illness // Przegl Epidemiol. – 2016. – V. 70. – № 3. – P. 490–499.
76. Folio L.R., Arkin K., Butler W.P. Frostbite in a mountain climber treated with hyperbaric oxygen: case report // Mil Med. – 2007. – V. 172. – № 5. – P. 560–563.
77. Staples J.R., Clement D. Hyperbaric oxygen chambers and the treatment of sports injuries // Sports Med. – 1996. – V. 22. – № 4. – P. 219–227.
78. Staples J.R. et al. Effects of hyperbaric oxygen on a human model of injury // Am J Sports Med. – 1999. – V. 27. – № 5. – P. 600–605.
79. Mekjavic I.B. et al. Hyperbaric oxygen therapy does not affect recovery from delayed onset muscle soreness // Med Sci Sports Exerc. – 2000. – V. 32. – № 3. – P. 558–563.
80. Harrison B.C., Robinson D., Davison B.J. et al. Treatment of exercise-induced muscle injury via hyperbaric oxygen therapy // Med Sci Sports Exerc. – 2001. – V. 33. – № 1. – P. 36–42.
81. Webster A.L. et al. Effects of hyperbaric oxygen on recovery from exercise-induced muscle damage in humans // Clin J Sport Med. – 2002. – V. 12. – № 3. – P. 139–150.
82. Dolezal V. Hyperbarická oxygenoterapie prizranĕní sportovců // Cas Lek Cesk. – 2002. – V. 141. – № 10. – P. 304–306.
83. Germain G. et al. Effect of hyperbaric oxygen therapy on exercise-induced muscle soreness // Undersea Hyperb Med. – 2003. – V. 30. – № 2. – P. 135–145.
84. Kanhai A., Losito J.M. Hyperbaric oxygen therapy for lower-extremity soft-tissue sports injuries // J Am Podiatr Med Assoc. – 2003. – V. 93. – № 4. – P. 298–306.
85. Drobnic F., Turmo A. Estado actual del tratamiento con oxígenohiperbárico de lasenfermedades del aparatolocomotor en medicina del deporte // Med Clin (Barc). – 2010. – V. 134. – № 7. – P. 312–315.
86. Yagishita K. et al. Effects of hyperbaric oxygen therapy on recovery acceleration in Japanese professional or semi-professional rugby players with grade 2 medial collateral ligament injury of the knee: a comparative non-randomized study // Undersea Hyperb Med. – 2019. – V. 46. – № 5. – P. 647–654.
87. Chen C.Y. et al. Early recovery of exercise-related muscular injury by HBOT // Biomed Res Int. – 2019. – V. 2019. – P. 6289380.
88. Woo J. et al. Effects of hyperbaric oxygen therapy on inflammation, oxidative/antioxidant balance, and muscle damage after acute exercise in normobaric, normoxic and hypobaric, hypoxic environments: a pilot study // Int J Environ Res Public Health. – 2020. – V. 17. – № 20. – P. 7377.
89. Rozenek R. et al. Does hyperbaric oxygen exposure affect high-intensity, short-duration exercise performance? // J Strength Cond Res. – 2007. – V. 21. – № 4. – P. 1037–1041.
90. Kawada S. et al. Effects of pre-exposure to hyperbaric hyperoxia on high-intensity exercise performance // J Strength Cond Res. – 2008. – V. 22. – № 1. – P. 66–74.
91. Barnett A. Using recovery modalities between training sessions in elite athletes: does it help? // Sports Med. – 2006. – V. 36. – № 9. – P. 781–796.
92. Ishii Y. et al. Hyperbaric oxygen as an adjuvant for athletes // Sports Med. – 2005. – V. 35. – № 9. – P. 739–746.
93. Figueroa X.A., Wright J.K. Clinical results in brain injury trials using HBO2 therapy: another perspective // Undersea Hyperb Med. – 2015. – V. 42. – № 4. – P. 333–351.
94. Самойлов А.С., Удалов Ю.Д., Шеянов М.В. и др. Опыт применения гипербарической оксигенотерапии с использованием портативных барокамер для лечения пациентов с новой коронавирусной инфекцией COVID-19 // Биомедицина. – 2020. – Т. 16. – № 2. – С. 39–46. [Samojlov A.S. et al. Experience of applicationing hyperbaric oxygen therapy using portable pressure chambers for the treatment of patients with a new coronavirus infection COVID-19 // Biomedica (Biomedicine). – 2020. – V. 16. – № 2. – P. 39–46. In Russian].
95. Thibodeaux K. et al. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series // J Wound Care. – 2020. – V. 29. – Suppl. 5a. – P. S4–S8.
96. Петриков С.С. и др. Гипербарическая оксигенация в терапии пациентов с COVID-19 // Общая реаниматология. – 2020. – Т. 16. – № 6. – С. 4–18. [Petrikov S.S. et al. Hyperbaric oxygen therapy in patients with COVID-19 // Obshchaya Reanimatologiya. – 2020. – V. 16. – № 6. – P. 4–18. In Russian].
97. Gorenstein S.A. et al. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls // Undersea Hyperb Med. – 2020. – V. 47. – № 3. – P. 405–413.
98. Kjellberg A., de Maio A., Lindholm P. Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19? // Med Hypotheses. – 2020. – V. 144. – P. 110224.
99. Kjellberg A. et al. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19 // BMJ Open. – 2021. – V. 11. – № 7. – P. e046738.
100. McMonnies C.W. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications // Clin Exp Optom. – 2015. – V. 98. – № 2. – P. 122–125.
101. McMonnies C. Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy // J Optom. – 2018. – V. 11. – № 1. – P. 3–9.
102. Пустовойт В.И. и др. Пилотное исследование по оценке эффективности психокорригирующих методов с использованием ЭЭГ-тренинга и очков виртуальной реальности у спортсменов, участвующих в экстремальных видах спорта // Спортивная медицина: наука и практика. – 2021. – Т. 11. – № 2. – С. 67–75. [Pustovoit V.I. et al. Pilot study on the evaluation of the effectiveness of psychocorrection methods that include EEG-training and VR headset in athletes involved in extreme kinds of sports // Sports medicine: research and practice. – 2021. – Т. 11. –№ 2. – P. 67–75. In Russian].
103. Самойлов А.С. и др. Применение методики анализа вариабельности сердечного ритма для определения индивидуальной устойчивости к токсическому действию кислорода // Спортивная медицина: наука и практика. – 2020. – Т. 10. – № 3. – С. 73–80. [Samoilov A.S. et al. Using heartrate variability to determine individual resistance to the hyperbaric oxygen toxicity // Sports medicine: research and practice. – 2020. – V. 10. – № 3. – P. 73–80. In Russian].
2. Mathieu D., Marroni A., Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment // Diving Hyperb Med. – 2017 – V. 47. – № 1. – P. 24–32.
3. Zeng Y. et al. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma // Brain Res. – 2012. – V. 3. – № 1452. – P. 140–50.
4. Hentia C. et al. An overview of protective strategies against ischemia/reperfusion injury: the role of hyperbaric oxygen preconditioning // Brain Behav. – 2018. – V. 30. – № 8. – P. 5.
5. Cozene B. et al. An extra breath of fresh air: hyperbaric oxygenation as a stroke therapeutic // Biomolecules. – 2020. – V. 10. – № 9. – P. 1279.
6. Hadanny A. et al. Hyperbaric oxygen therapy – basics and new applications // Harefuah. – 2018. – V. 157. – № 5. – P. 322–326.
7. Hadanny A. et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis // Restor Neurol Neurosci. – 2020. – V. 38. – № 1. – P. 93–107.
8. Liang X.X. et al. Hyperbaric oxygen therapy for post-stroke depression: a systematic review and meta-analysis // Clin Neurol Neurosurg. – 2020. – V. 195. – P. 105910.
9. Schiavo S. et al. Hyperbaric oxygen and focused rehabilitation program: a feasibility study in improving upper limb motor function after stroke // Appl Physiol Nutr Metab. – 2020. – V. 45. – № 12. – P. 1345–1352.
10. Sankaran R., Radhakrishnan K., Sundaram K.R. Hyperbaric oxygen therapy in patients with hypoxic ischemic encephalopathy // Neurol India. – 2019. – V. 67. – № 3. – P. 728–731.
11. Golan H. et al. Imaging-based predictors for hyperbaric oxygen therapy outcome in post-stroke patients. Report 1 // Med Hypotheses. – 2020. – V. 136. – P. 109510.
12. Deng Z. et al. The neuroprotection effect of oxygen therapy: a systematic review and meta-analysis // Niger J Clin Pract. – 2018. – V. 21. – № 4. – P. 401–416.
13. Daly S. et al. Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review // J Neurotrauma. – 2018. – V. 35. – № 4. – P. 623–629.
14. Zhong X. et al. Hyperbaric oxygen for severe traumatic brain injury: a randomized trial // J Int Med Res. – 2020. – V. 48. – № 10. – P. 300060520939824.
15. Boussi-Gross R. et al. Hyperbaric oxygen therapy can improve post-concussion syndrome years after mild traumatic brain injury – а randomized prospective trial // PLoS One. – 2013. – V. 8. – № 11. – P. e79995.
16. Sutherland A.M. Hyperbaric oxygen therapy: a new treatment for chronic pain? // Pain Pract. – 2016. – V. 16. – № 5. – P. 620–628.
17. Zelinski L.M. et al. A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice // J Pain. – 2009. – V. 10. – № 2. – P. 167–172.
18. Chung E.et al. Hyperbaric oxygen treatment induces a 2-phase antinociceptive response of unusually long duration in mice // J Pain. – 2010. – V. 11. – № 9. – P. 847–853.
19. Hui J. et al. Repetitive hyperbaric oxygen treatment attenuates complete Freund's adjuvant-induced pain and reduces glia-mediated neuroinflammation in the spinal cord // J Pain. – 2013. – V. 14. – № 7. – P. 747–758.
20. Bennett M.H. et al. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache // Cochrane Database Syst Rev. – 2015. – V. 28. – № 12. – P. CD005219.
21. Atzeni F. et al. Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system // Clin Exp Rheumatol. – 2020. – V. 38. – Suppl. 123. – № 1. – P. 94–98.
22. Kusuda Y. et al. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantianigra of mice with MPTP-induced Parkinson's disease // Neurosci Res. – 2018. – V. 132. – P. 58–62.
23. Uezato A. et al. Shorter sleep onset latency in patients undergoing hyperbaric oxygen treatment // Psychiatry Clin Neurosci. – 2017. – V. 71. – № 1. – P. 73–74.
24. Hyldegaard O., Hedetoft M. Hyperbaric oxygen therapy // Ugeskr Laeger. – 2020. – V. 182. – № 44. – P. V06200463.
25. Wu Z.S. et al. Early hyperbaric oxygen treatment attenuates burn-induced neuroinflammation by inhibiting the galectin-3-dependent toll-like receptor-4 pathway in a rat model // Int J Mol Sci. – 2018. – V. 19. – № 8. – P. 2195.
26. Memar M.Y. et al. Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections // Biomed Pharmacother. – 2019. – V. 109. – P. 440–447.
27. Lam G. et al. Hyperbaric oxygen therapy: exploring the clinical evidence // Adv Skin Wound Care. – 2017. – V. 30. – № 4. – P. 181–190.
28. Gunes A.E., Cimsit M. Can amputation be prevented in diabetic foot? Interdisciplinary approach to diabetic foot: a case report // Undersea Hyperb Med. – 2017. – V. 44. – № 2. – P. 157–160.
29. Chen C.Y. et al. Adjunctive hyperbaric oxygen therapy for healing of chronic diabetic foot ulcers: a randomized controlled trial // J Wound Ostomy Continence Nurs. – 2017. – V. 44. – № 6. – P. 536–545.
30. Bolton L. Does hyperbaric oxygen improve lower extremity ulcer outcomes? // Wounds. – 2020. – V. 32. – № 10. – P. 291–293.
31. Henshaw F.R., Brennan L., MacMillan F. Perceptions of hyperbaric oxygen therapy among podiatrists practicing in high-risk foot clinics // Int Wound J. – 2018. – V. 15. – № 3. – P. 375–382.
32. Kahraman C., Yaman H. Hyperbaric oxygen therapy affects insulin sensitivity/resistance by increasing adiponectin, resistin, and plasminogen activator inhibitor-I in rats // Turk J Med Sci. – 2021. – V. 51. – № 3. – P. 1572–1578.
33. Charaghvandi D.A., Teguh D.N., van Hulst R.A. Hyperbaric oxygen therapy in patients suffering from wounds in calciphylaxis: a narrative review // Undersea Hyperb Med. – 2020. – V. 47. – № 1. – P. 111–123.
34. Koh S.L. et al. The effect of hyperbaric oxygen on apoptosis and proliferation in severe acute pancreatitis // HPB (Oxford). – 2009. – V. 11. – № 8. – P. 629–637.
35. Bai X., Song Z., Zhou Y. et al. The apoptosis of peripheral blood lymphocytes promoted by hyperbaric oxygen treatment contributes to attenuate the severity of early stage acute pancreatitis in rats // Apoptosis. – 2014. – V. 19. – № 1. – P. 58–75.
36. Christophi C. et al. Hyperbaric oxygen therapy for severe acute pancreatitis // J Gastroenterol Hepatol. – 2007. – V. 22. – № 11. – P. 2042–2046.
37. Weitgasser L. et al. Update on hyperbaric oxygen therapy in burn treatment // Wien Klin Wochenschr. – 2021. – V. 133. – № 3–4. – P. 137–143.
38. Edwards M. et al. Hyperbaric treatment of thermal burns // StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
39. Halbach J.L. et al. Early hyperbaric oxygen therapy improves survival in a model of severe sepsis // Am J Physiol Regul Integr Comp Physiol. – 2019. – V. 317. – № 1. – P. 160–168.
40. Harl M.J. Defining the role of hyperbaric oxygen therapy as an adjunct to reconstructive surgery // Surg Clin North Am. – 2020. – V. 100. – № 4. – P. 777–785.
41. Bush N., Snodgrass W. Hyperbaric oxygen therapy improves oral graft take in hypospadias staged tubularized autograft reoperations // J Urol. – 2019. – V. 202. – № 3. – P. 617–622.
42. Fan Z.X. et al. The effect of hyperbaric oxygen therapy combined with hair transplantation surgery for the treatment of alopecia // J Cosmet Dermatol. – 2021. – V. 20. – № 3. – P. 917–921.
43. Willy C., Rieger H., Vogt D. Hyperbare oxygenation bei nekrotisieren den Weichteilinfektionen: Kontra // Chirurg. – 2012. – V. 83. – № 11. – P. 960–972.
44. Levett D., Bennett M.H., Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis // Cochrane Database Syst Rev. – 2015. – V. 1. – № 1. P. CD007937.
45. Schmale M. et al. Hyperbare oxygenation bei nekrotisieren den Weichteilinfektionen: Pro // Chirurg. – 2012. – V. 83. – № 11. – P. 973–979.
46. Shaw J.J. et al. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections // Surg Infect (Larchmt). – 2014. – V. 15. – № 3. – P. 328–335.
47. Moen I., Stuhr L.E. Hyperbaric oxygen therapy and cancer – a review // Target Oncol. – 2012. – V. 7. – № 4. – P. 233–242.
48. Stępień K., Ostrowski R.P., Matyja E. Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours // Med Oncol. – 2016. – V. 33. – № 9. – P. 101.
49. Zembrzuska K., Ostrowski R.P., Matyja E. Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro // Oncol Rep. – 2019. – V. 41. – № 5. – P. 2703–2716.
50. Chen S.Y. et al. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer // Sci Rep. – 2021. – V. 11. – № 1. – P. 12033.
51. Oscarsson N. et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2–3 trial // Lancet Oncol. – 2019. – V. 20. – № 11. – P. 1602–1614.
52. Feldmeier J.J. Hyperbaric oxygen for radiation cystitis // Lancet Oncol. – 2019. – V. 20. – № 11. – P. 1481–1482.
53. Clarke R. Radiation-induced cystitis and hyperbaric oxygen therapy // Lancet Oncol. – 2019. – V. 20. – № 12. – P. e660.
54. Buckey J.C. Use of gases to treat cochlear conditions // Front Cell Neurosci. – 2019. – V. 24. – № 13. – P. 155.
55. Bayoumy A.B. et al. Effect of hyperbaric oxygen therapy and corticosteroid therapy in military personnel with acute acoustic trauma // BMJ Mil Health. – 2020. – V. 166. – № 4. – P. 243–248.
56. Holy R. et al. The use of hyperbaric oxygen therapy and corticosteroid therapy in acute acoustic trauma: 15 years' experience at the Czech military health service // Int J Environ Res Public Health. – 2021. – V. 18. – № 9. – P. 4460.
57. Cobanoglu H.B. et al. Is hyperbaric oxygen therapy effective in cisplatin-induced ototoxicity in rats? // Clin Exp Otorhinolaryngol. – 2019. – V. 12. – № 1. – P. 66–71.
58. Ajduk J. et al. Hyperbaric oxygen therapy as salvage therapy for sudden sensorineural hearing loss // J Int Adv Otol. – 2017. – V. 13. – № 1. – P. 61–64.
59. Cho I. et al. Comparison of two different treatment protocols using systemic and intratympanic steroids with and without hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss: a randomized controlled trial // Audiol Neurootol. – 2018. – V. 23. – № 4. – P. 199–207.
60. Stachler R.J. et al. Clinical practice guideline: sudden hearing loss // Otolaryngol Head Neck Surg. – 2012. – V. 146. – № 3. – P. 1–35.
61. Bagli B.S. Clinical efficacy of hyperbaric oxygen therapy on idiopathic sudden sensorineural hearing loss // Undersea Hyperb Med. – 2020. – V. 47. – № 1. – P. 51–56.
62. Murphy-Lavoie H. et al. Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss // Undersea Hyperb Med. – 2012. – V. 39. – № 3. – P. 777–792.
63. van der Wal A.W., van Ooij P.J.A.M., de Ru J.A. Hyperbaric oxygen therapy for sudden sensorineural hearing loss in divers // J Laryngol Otol. – 2016. – V. 130. – № 11. – P. 1039–1047.
64. Hu Y. et al. The efficacy of hyperbaric oxygen in the treatment of sudden sensorineural hearing loss // Lin Chung Er Bi Yan HouTou Jing Wai Ke Za Zhi. – 2020. – V. 34. – № 6. – P. 521–523; 527.
65. Olex-Zarychta D. Hyperbaric oxygenation as adjunctive therapy in the treatment of sudden sensorineural hearing loss // Int J Mol Sci. – 2020. – V. 21. – № 22. – P. 8588.
66. Yang C.C. et al. The occurrence of delayed neuropsychologic sequelae in acute carbon monoxide poisoning patients after treatment with hyperbaric or normobaric oxygen therapy // Medicine (Baltimore). – 2021. – V. 100. – № 2. – P. e24183.
67. Zhang L. et al. Hyperbaric oxygen therapy mobilized circulating stem cells and improved delayed encephalopathy after acute carbon monoxide poisoning with up-regulation of brain-derived neurotrophic factor // Am J Emerg Med. – 2021. – V. 42. – P. 95–100.
68. Açiksari K. et al. Protective effect of hyperbaric oxygen treatment on rat intestinal mucosa after mesenteric ischaemia and reperfusion // Diving Hyperb Med. – 2019. – V. 49. – № 4. – P. 253–258.
69. Leitman M. et al. The effect of hyperbaric oxygenation therapy on myocardial function // Int J Cardiovasc Imaging. – 2020. – V. 36. – № 5. – P. 833–840.
70. Bennett M.H., Lehm J.P., Jepson N. Hyperbaric oxygen therapy for acute coronary syndrome // Cochrane Database Syst Rev. – 2015. – V. 2015. – № 7. – P. CD004818.
71. Gardin C. et al. Hyperbaric oxygen therapy improves the osteogenic and vasculogenic properties of mesenchymal stem cells in the presence of inflammation in vitro // Int J Mol Sci. – 2020. – V. 21. – № 4. – P. 1452.
72. Fosen K.M., Thom S.R. Hyperbaric oxygen, vasculogenic stem cells, and wound healing // Antioxid Redox Signal. – 2014. – V. 21. – № 11. – P. 1634–1647.
73. Kirby J.P. The diagnosis of decompression sickness in sport divers // Mo Med. – 2019. – V. 116. – № 3. – P. 195–197.
74. Butler G.J. et al. Altitude mountain sickness among tourist populations: a review and pathophysiology supporting management with hyperbaric oxygen // J Med Eng Technol. – 2011. – V. 35. – № 3–4. – P. 197–207.
75. Hartman-Ksycińska A., Kluz-Zawadzka J., Lewandowski B. High altitude illness // Przegl Epidemiol. – 2016. – V. 70. – № 3. – P. 490–499.
76. Folio L.R., Arkin K., Butler W.P. Frostbite in a mountain climber treated with hyperbaric oxygen: case report // Mil Med. – 2007. – V. 172. – № 5. – P. 560–563.
77. Staples J.R., Clement D. Hyperbaric oxygen chambers and the treatment of sports injuries // Sports Med. – 1996. – V. 22. – № 4. – P. 219–227.
78. Staples J.R. et al. Effects of hyperbaric oxygen on a human model of injury // Am J Sports Med. – 1999. – V. 27. – № 5. – P. 600–605.
79. Mekjavic I.B. et al. Hyperbaric oxygen therapy does not affect recovery from delayed onset muscle soreness // Med Sci Sports Exerc. – 2000. – V. 32. – № 3. – P. 558–563.
80. Harrison B.C., Robinson D., Davison B.J. et al. Treatment of exercise-induced muscle injury via hyperbaric oxygen therapy // Med Sci Sports Exerc. – 2001. – V. 33. – № 1. – P. 36–42.
81. Webster A.L. et al. Effects of hyperbaric oxygen on recovery from exercise-induced muscle damage in humans // Clin J Sport Med. – 2002. – V. 12. – № 3. – P. 139–150.
82. Dolezal V. Hyperbarická oxygenoterapie prizranĕní sportovců // Cas Lek Cesk. – 2002. – V. 141. – № 10. – P. 304–306.
83. Germain G. et al. Effect of hyperbaric oxygen therapy on exercise-induced muscle soreness // Undersea Hyperb Med. – 2003. – V. 30. – № 2. – P. 135–145.
84. Kanhai A., Losito J.M. Hyperbaric oxygen therapy for lower-extremity soft-tissue sports injuries // J Am Podiatr Med Assoc. – 2003. – V. 93. – № 4. – P. 298–306.
85. Drobnic F., Turmo A. Estado actual del tratamiento con oxígenohiperbárico de lasenfermedades del aparatolocomotor en medicina del deporte // Med Clin (Barc). – 2010. – V. 134. – № 7. – P. 312–315.
86. Yagishita K. et al. Effects of hyperbaric oxygen therapy on recovery acceleration in Japanese professional or semi-professional rugby players with grade 2 medial collateral ligament injury of the knee: a comparative non-randomized study // Undersea Hyperb Med. – 2019. – V. 46. – № 5. – P. 647–654.
87. Chen C.Y. et al. Early recovery of exercise-related muscular injury by HBOT // Biomed Res Int. – 2019. – V. 2019. – P. 6289380.
88. Woo J. et al. Effects of hyperbaric oxygen therapy on inflammation, oxidative/antioxidant balance, and muscle damage after acute exercise in normobaric, normoxic and hypobaric, hypoxic environments: a pilot study // Int J Environ Res Public Health. – 2020. – V. 17. – № 20. – P. 7377.
89. Rozenek R. et al. Does hyperbaric oxygen exposure affect high-intensity, short-duration exercise performance? // J Strength Cond Res. – 2007. – V. 21. – № 4. – P. 1037–1041.
90. Kawada S. et al. Effects of pre-exposure to hyperbaric hyperoxia on high-intensity exercise performance // J Strength Cond Res. – 2008. – V. 22. – № 1. – P. 66–74.
91. Barnett A. Using recovery modalities between training sessions in elite athletes: does it help? // Sports Med. – 2006. – V. 36. – № 9. – P. 781–796.
92. Ishii Y. et al. Hyperbaric oxygen as an adjuvant for athletes // Sports Med. – 2005. – V. 35. – № 9. – P. 739–746.
93. Figueroa X.A., Wright J.K. Clinical results in brain injury trials using HBO2 therapy: another perspective // Undersea Hyperb Med. – 2015. – V. 42. – № 4. – P. 333–351.
94. Самойлов А.С., Удалов Ю.Д., Шеянов М.В. и др. Опыт применения гипербарической оксигенотерапии с использованием портативных барокамер для лечения пациентов с новой коронавирусной инфекцией COVID-19 // Биомедицина. – 2020. – Т. 16. – № 2. – С. 39–46. [Samojlov A.S. et al. Experience of applicationing hyperbaric oxygen therapy using portable pressure chambers for the treatment of patients with a new coronavirus infection COVID-19 // Biomedica (Biomedicine). – 2020. – V. 16. – № 2. – P. 39–46. In Russian].
95. Thibodeaux K. et al. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series // J Wound Care. – 2020. – V. 29. – Suppl. 5a. – P. S4–S8.
96. Петриков С.С. и др. Гипербарическая оксигенация в терапии пациентов с COVID-19 // Общая реаниматология. – 2020. – Т. 16. – № 6. – С. 4–18. [Petrikov S.S. et al. Hyperbaric oxygen therapy in patients with COVID-19 // Obshchaya Reanimatologiya. – 2020. – V. 16. – № 6. – P. 4–18. In Russian].
97. Gorenstein S.A. et al. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls // Undersea Hyperb Med. – 2020. – V. 47. – № 3. – P. 405–413.
98. Kjellberg A., de Maio A., Lindholm P. Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19? // Med Hypotheses. – 2020. – V. 144. – P. 110224.
99. Kjellberg A. et al. Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19 // BMJ Open. – 2021. – V. 11. – № 7. – P. e046738.
100. McMonnies C.W. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications // Clin Exp Optom. – 2015. – V. 98. – № 2. – P. 122–125.
101. McMonnies C. Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy // J Optom. – 2018. – V. 11. – № 1. – P. 3–9.
102. Пустовойт В.И. и др. Пилотное исследование по оценке эффективности психокорригирующих методов с использованием ЭЭГ-тренинга и очков виртуальной реальности у спортсменов, участвующих в экстремальных видах спорта // Спортивная медицина: наука и практика. – 2021. – Т. 11. – № 2. – С. 67–75. [Pustovoit V.I. et al. Pilot study on the evaluation of the effectiveness of psychocorrection methods that include EEG-training and VR headset in athletes involved in extreme kinds of sports // Sports medicine: research and practice. – 2021. – Т. 11. –№ 2. – P. 67–75. In Russian].
103. Самойлов А.С. и др. Применение методики анализа вариабельности сердечного ритма для определения индивидуальной устойчивости к токсическому действию кислорода // Спортивная медицина: наука и практика. – 2020. – Т. 10. – № 3. – С. 73–80. [Samoilov A.S. et al. Using heartrate variability to determine individual resistance to the hyperbaric oxygen toxicity // Sports medicine: research and practice. – 2020. – V. 10. – № 3. – P. 73–80. In Russian].